Flexion Therapeutics Obtains $20,000,000 Series B Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=01bc29a0-f5ce-4692-8aa5-23053bad65a6&Preview=1 -
Date
12/4/2012 -
Company Name
Flexion Therapeutics -
Mailing Address
300 TradeCenter Woburn, MA 01801 -
Company Description
Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners. -
Website
http://www.flexiontherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds will be used to fund late stage clinical development of the company’s portfolio of intra-articular, sustained release therapies for the treatment of osteoarthritis. -
M&A Terms
-
Venture Investor
Novo A/S -
Venture Investor
5AM Ventures -
Venture Investor
Pfizer Venture Investments -
Venture Investor
Sofinnova Ventures -
Venture Investor
Versant Ventures -
Venture Investor
Versant Ventures
